Clinical features and laboratory findings of SARS-CoV-2 infection in hospitalized patients

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a new emerging public health crisis to the world. However, data are still limited on the clinical features and laboratory findings in COVID-19 patients.Methods: Medical records including demographics characteristics, clinical features, laboratory findings and radiological materials of 66 hospitalized COVID-19 patients were collected between Jan 23 and Mar 9, 2020. Symptoms/signs with potential association with the disease severity were analyzed.Results: Of 66 hospitalized COVID-19 patients, the male-to-female ratio was 44:22. There were eight cases potentially exposed to one single patient. The most common initial symptoms of SARS-CoV-2 infection were fever (77.3%) and cough (74.2%). Compared to those with non-severe infection, the severe patients were more likely to be older (62.6 ± 15.1 vs 46.9 ± 13.3 years. P = 0.001) and with more infected lobes. As the results shown, higher initial (on admission) and peak (during hospitalization) counts of lymphocyte were inversely associated with the severe SARS-CoV-2 infection (both OR: 0.01 every 1´109/L decrease). However, the elevated initial neutrophil counts (OR: 1.63 every 1´109/L increase), initial and peak levels of LDH (OR: 1.02 and 1.01 every 1 U/L increase), peak levels of CRP (OR: 1.03 every 1 mg/L increase), AST (OR: 1.06 every 1 U/L increase) and ALT (OR: 1.02 every 1 U/L increase) were significantly associated with COVID-19 severity.Conclusion: Our present study indicated that fever and cough were the most common initial symptoms of SARS-CoV-2 infection, and the virus could be efficiently spread by person-to-person transmission. In addition, lymphocyte and neutrophil counts, and serum levels of AST, ALT, CRP and LDH should be useful for the evaluation on COVID-19 severity.

[1]  M. Palacios Cruz,et al.  COVID-19, una emergencia de salud pública mundial , 2020, Revista Clínica Española.

[2]  Huan Cai,et al.  Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings , 2020, International Journal of Infectious Diseases.

[3]  Qiu Zhao,et al.  Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Char Leung Clinical features of deaths in the novel coronavirus epidemic in China , 2020, Reviews in medical virology.

[5]  Wenjie Yang,et al.  Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China. , 2020, AJR. American journal of roentgenology.

[6]  Yuxin Shi,et al.  Clinical progression of patients with COVID-19 in Shanghai, China , 2020, Journal of Infection.

[7]  Yuyi Wang,et al.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.

[8]  W. Ko,et al.  Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.

[9]  D. Murdoch,et al.  Clinical course and mortality risk of severe COVID-19 , 2020, The Lancet.

[10]  C. Shi,et al.  Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series , 2020, medRxiv.

[11]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[12]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[13]  P. Horby,et al.  A novel coronavirus outbreak of global health concern , 2020, The Lancet.

[14]  Taisheng Li Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) , 2020, Emerging microbes & infections.

[15]  D. Barreca,et al.  Lactate dehydrogenase inhibition: biochemical relevance and therapeutical potential. , 2019, Current medicinal chemistry.

[16]  J. Ashworth,et al.  Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..

[17]  D. McClish,et al.  Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia , 2016, Travel Medicine and Infectious Disease.

[18]  Kow-Tong Chen,et al.  Hematological and Biochemical Factors Predicting SARS Fatality in Taiwan , 2006, Journal of the Formosan Medical Association.

[19]  Y. Leo,et al.  Clinical and epidemiological predictors of transmission in Severe Acute Respiratory Syndrome (SARS) , 2006, BMC infectious diseases.

[20]  Y. Leo,et al.  SARS in Singapore--predictors of disease severity. , 2006, Annals of the Academy of Medicine, Singapore.

[21]  R. Perng,et al.  Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome , 2005, Journal of the Chinese Medical Association.

[22]  Chong-Jen Yu,et al.  Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients , 2004, Emerging infectious diseases.

[23]  S. Sethi,et al.  Severe Acute Respiratory Syndrome without Respiratory Symptoms or Abnormal Chest Radiograph Findings , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.